✦ LIBER ✦

Severe cutaneous ulceration following treatment with thalidomide for GVHD

✍ Scribed by Schlossberg, H; Klumpp, T; Sabol, P; Herman, J; Mangan, K

Book ID: 110012920
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 83 KB
Volume: 27
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702756

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe cutaneous toxicity following trea

Severe cutaneous toxicity following treatment with gefitinib (ZD1839)

✍ J.C. Pascual; I. Belinchón; F. Sivera; A. Yuste 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Severe neutropenia following infliximab

Severe neutropenia following infliximab treatment in a child with ulcerative colitis

✍ Mary Sherlock; Robert Bandsma; Kaede Ota; Melanie Kirby-Allen; Anne Griffiths 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

Successful combination treatment with be

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome

✍ Ohwada, C; Nakaseko, C; Sakai, S; Takeda, Y; Abe, D; Takeuchi, M; Sakaida, E; Ma 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Severe pneumococcal pneumonia following

Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease

✍ Dr.; Dr. Marc A. Ritz; Res Jost 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Exogenous alkaline phosphatase for the t

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis

✍ Milan Lukas; Pavel Drastich; Michal Konecny; Paolo Gionchetti; Ondrej Urban; Fra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Background: Increased activity of intestinal alkaline phosphatase (AP) occurs locally in patients with ulcerative colitis (UC), aimed at repairing inflammatory tissue damage. We evaluated the safety and preliminary efficacy of exogenous AP administered to patients with UC in an open-label, first-in-

Single-agent thalidomide for treatment o

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

✍ Fenk, R; Hoyer, B; Steidl, U; Kondakci, M; Graef, T; Heuk, R; Ruf, L; Strupp, C; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB